DocGo (DCGO) Acquires PTI Health

DocGo Inc. (Nasdaq: DCGO) (“DocGo” or the “Company”), a leading provider of technology-enabled mobile health services, today announced the acquisition of PTI Health, a mid-Atlantic mobile lab collection and phlebotomy services company. This strategic move expands DocGo’s healthcare service offering to include mobile phlebotomy lab services, addressing critical gaps in diagnostic care for underserved populations. With this acquisition, DocGo will facilitate timely, convenient blood collection and additional at-home testing services for patients, offering a new level of care to those with limited access to traditional labs or transportation options.

The acquisition enhances DocGo’s offerings by leveraging PTI Health’s existing partnerships and ordering platform integrations with the nation’s two largest labs, and will facilitate PTI Health’s expansion into new markets. Initially, DocGo plans to expand PTI Health’s operations into New York City, addressing critical gaps in facilitating lab and diagnostic services in one of the nation’s largest urban markets.

“PTI Health has a great team and integrations with the largest laboratory service providers in the US – we are incredibly excited to complete this transaction. By incorporating PTI Health’s mobile lab collection, phlebotomy services and clinical staff, we’re expanding our mobile health offerings and further strengthening our vertically integrated care model to bring diagnostic and primary care services to patients across our footprint,” said Lee Bienstock, CEO of DocGo. “We believe this acquisition is a good example of our ability to expand our offering while leveraging our existing customer base to drive further growth at PTI. We are constantly seeking opportunities to leverage our balance sheet to complement our growth in 2025 and beyond.”

PTI Health specializes in serving patients who are homebound or face transportation challenges, and their clinicians perform thousands of lab collections every year. PTI Health’s experienced mobile phlebotomists perform in-home blood draws and other collections, enabling seamless diagnostics and care gap closure in collaboration with patients’ healthcare providers. PTI also supports mobile clinical trials, adding a new dimension to DocGo’s robust healthcare offering.

As part of the acquisition, PTI Health President Wayne Meadows will join DocGo as a General Manager. “I’m excited to join DocGo and expand on PTI Health’s success bringing vital lab services to patients,” said Meadows. “DocGo delivers a world-class patient experience, as evidenced by their 2024 mobile health Net Promoter Score (NPS) of 86. I look forward to working together to elevate PTI Health’s offering and expand our services across DocGo’s entire US footprint to provide vital healthcare access to even more patients.”

You May Also Be Interested In

• Deep Fission reports 18.5 GW in non-binding nuclear pipeline
• Devon Energy completes exchange of Coterra notes for new Devon debt
• VERAXA Biotech expands lab space at Heidelberg R&D site